<?xml version="1.0" encoding="UTF-8"?>
<p>For people with hypogonadism, continuing the same regimen of hormone replacement until a visit to the health care provider is advisable. There might be difficulty in accessing medications including testosterone injections. It may be reasonable to postpone replacement in case of lack of availability until nonurgent services resume because there are no major hazards of temporary discontinuation. However, substitution of the alternative dosage forms is an option. If testosterone gel preparation is substituted for injections, the gel can be commenced from the due date of the next testosterone injection [
 <xref rid="CIT0058" ref-type="bibr">58</xref>]. In the case of female hormone replacement, it may be preferable to use transdermal formulations that are less likely to lead to a hypercoagulable state.
</p>
